Response by Pan and Sun to Letter Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture"

Affiliations

Comment

Lihong Pan et al. Circulation. 2022.

. 2022 Sep 13;146(11):e144-e145.

doi: 10.1161/CIRCULATIONAHA.122.060916. Epub 2022 Sep 12.

¹ Institutes of Biomedical Science and Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

No abstract available

Comment on

Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture.
Pan L, Bai P, Weng X, Liu J, Chen Y, Chen S, Ma X, Hu K, Sun A, Ge J. Pan L, et al. Circulation. 2022 Mar;145(9):659-674. doi: 10.1161/CIRCULATIONAHA.121.056640. Epub 2022 Jan 31. Circulation. 2022. PMID: 35100526
Letter by Wang et al Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture".
Wang D, Ma Z, Wang T. Wang D, et al. Circulation. 2022 Sep 13;146(11):e142-e143. doi: 10.1161/CIRCULATIONAHA.122.060398. Epub 2022 Sep 12. Circulation. 2022. PMID: 36095060 No abstract available.